Jun 30, 2018

United Therapeutics Q2 2018 Earnings Report

Total Revenue
$445M
Previous year: $445M
+-0.0%
EPS
$4.36
Previous year: $4.37
-0.2%
Gross Profit
$383M
Previous year: $426M
-10.1%
Cash and Equivalents
$746M
Previous year: $1.01B
-25.8%
Free Cash Flow
$126M
Previous year: $49.8M
+153.6%
Total Assets
$3.24B
Previous year: $2.69B
+20.6%

United Therapeutics

United Therapeutics